:::回首頁English網站導覽常見問答聯絡我們舊版www  
本院簡介 研究單位 技術移轉 研究資源 圖書館 訊息公告 院內網站
 
::: 首頁>
* * *
*
 
亞太消化道腫瘤研討會暨第八屆TCOG年會
臺灣癌症臨床研究合作組織 (TCOG)
 

II. 研討會影音

亞太消化道腫瘤研討會暨第八屆TCOG年會 (Dec. 4 (Saturday), 2004)

Session I: Symposium on Colorectal Cancer (I)

 
Topic Speaker
Advances in the First Line Treatment of Advanced Colorectal Cancer Richard M
Goldberg, University of North Carolina at Chapel Hill, USA
Targeted Therapies for the Treatment of Advanced Colorectal Cancer Edward Chu
Yale University School of Medicine, USA
Targeted Anticancer Therapies: New Paradigms for Drug Development Chris H. M. Takimoto
Cancer Therapy and Research Center, USA
Molecular Profiling of Colorectal Cancer Robert B. Diasio
University of Alabama at Birmingham, USA
rTS Signaling Pathway: New Pre-clinical Strategies for Drug Development in Colorectal Cancer Bruce J. Dolnick
Roswell Park Cancer Institute, USA
TOP
transPix

Session II: Symposium on Gastric Cancer

 
Topic Speaker
The Systemic Therapy of Gastric Cancer: Current and Future Trends Philip Agop Philip
Wayne State University, USA
Current Status and New Advances of Chemotherapy in Gastric Cancer Tetsuo Taguchi
Japan Society for Cancer Chemotherapy, Japan
Current Status of Adjuvant Chemotherapy in Gastric and Colorectal Cancer Masashi Fujii
Nihon University, Japan
Role of Nodal Dissection for Gastric Cancer: Taipei Randomized Trial Chew-Wun Wu
(吳秋文)
TOP
transPix

Session II: Symposium on Colorectal Cancer (II)

 
Topic Speaker
Adjuvant Therapy in Colon Cancer Richard M. Goldberg
University of North Carolina at Chapel Hill, NC, USA
New Approaches for the Treatment of Rectal Cancer Edward Chu
Yale University School of Medicine, USA
Novel Targeted Cancer Therapies; Clinical Development Programs at the National Cancer Institute John Joseph Wright
National Cancer Institute, USA
TOP
transPix

Session IV: Symposium on Hepatocellular Carcinoma

 
Topic Speaker
Chemotherapy for Hepatocellular Carcinoma: Reality and Challenge; and Development of Novel Therapy Weijing Sun,
University of Pennsylvania, USA
Effects of Lamivudine on Development of Hepatocellular Carcinoma in Advanced Chronic Hepatitis B Rong-Nan Chien
(簡榮南)
Adjuvant Interferon Alfa-2b Significantly Improves the Survival in Curatively Resected High-risk Hepatocellular Carcinoma – The Taiwan Cooperative Oncology Group (T1297) Study Li-Tzong Chen
(陳立宗)
TOP
transPix

 

回上一層

 

*
* * *
     
  私隱政策與免責聲明 | 財團法人國家衛生研究院版權所有
苗栗縣竹南鎮 35053 科研路35號 -- 電話: +886-37-246-166
台北市南港區 11503 園區街3號10樓(南港軟體園區F棟) -- 電話: +886-2-2653-4401
台南市北區 70456 勝利路367號(統一健康研究大樓) -- 電話: +886-6-700-0123
各單位分機代表號
電子信箱:webmaster@nhri.org.tw